Skip to content

APOTHEEK AMPE

Active Private limited companyfounded 2006active for 20 yearsDoorniksewijk 33, 8500 KortrijkKBO/BCE: BE 0878.742.301 subsidiary of AMHE

Board

1 director, last change in 2024
AMHE BV
Director, permanent representative Heleen Ampe
since 01-01-2024
listed in the 2025 annual accounts, filed on 01-07-2026
Permanent representatives 1
Heleen Ampe
Permanent representative, for AMHE
appointed by deed of 01-02-2024

Office holders in the KBO →

Mandates through the years

3 names, the dashed line is today
AMHE
Director
AMVA
Director (not named in the articles)
Marc Ampe
Statutory manager
BoardEarliermandate already running before its first mention
Mandates as a list
  • AMHE
    • Director, since before 31-12-2023
  • AMVA
    • Director (not named in the articles), from 05-11-2014 to 01-02-2024
    • Manager, until 23-06-2023
  • Marc Ampe
    • Statutory manager, until 06-11-2014

Control

Parent
Equity €222,322
Profit €10,357 in 2025 (profit €13,559 in 2024)
100%
This company
APOTHEEK AMPE
Equity €194,416
Loss €22,969 in 2025

Capital

Contribution
€118,600
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
Owners as a list

Source: lists of holdings in the owners' accounts

Articles of association

deed of 23-06-2023 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Helft overdrager helft kopers naar evenredigheid aantal als meer dan één koper, werkelijke waarde op dag overdracht”
Share issue ruleThe articles set how and by whom new shares are issued.
“Voorkeurrecht toe aan eigenaar-pandgever, alle aandeelhouders kunnen afstand doen bij besluit algemene vergadering tot uitgifte”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Saturday of June at 14:00

Next steps